B. Riley Has Positive Forecast for Cytokinetics Q2 Earnings
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Stock analysts at B. Riley boosted their Q2 2025 earnings estimates for Cytokinetics in a research note issued on Wednesday, May 7th. B. Riley analyst M. Mamtani now expects that the biopharmaceutical company will post earnings per share of ($1.37) for the quarter, up from their previous estimate […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Stock analysts at B. Riley boosted their Q2 2025 earnings estimates for Cytokinetics in a research note issued on Wednesday, May 7th. B. Riley analyst M. Mamtani now expects that the biopharmaceutical company will post earnings per share of ($1.37) for the quarter, up from their previous estimate […]
